Airway Management Devices Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Global Airway Management Devices Market is Segmented By Type (Laryngoscopes, Infraglottic Airway Management Devices, Supraglottic Airway Management Devices, Resuscitators, Cricothyrotomy Kits, Others), By Age (Pediatrics/Neonates, Adults), By End User (Hospitals, Ambulatory Surgical Centers, Others), and By Region  (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024 - 2031

Airway Management Devices Market

The global airways management devices market is US$  million in 2023 and is estimated to grow at a High  CAGR during the forecast period (2024-2031) to reach a value of US$  million in 2031.

Airway management is required for individuals in a variety of circumstances, ranging from simple choking to complicated airway obstruction. Airway obstruction most commonly occurs as a result of the tongue or foreign bodies blocking the airway. It can also be the result of injury to the airway, increased presence of blood and secretions (e.g., saliva and mucus), or inflammation of the airway.

The airway management devices market is driven by various factors like rising prevalence of respiratory diseases, and as the number of surgeries increases,, the increase in healthcare spending, advancements in healthcare infrastructure, and a high demand for expanded care delivery all benefit the airway management device market. The North America region is expected to have highest market owing to the introduction of new technologies in devices of airway management by key players. Moreover, increasing collaborations among manufacturing players and rising approvals of new airway devices with extensive presence across the region also drive the this region in future.

Airway management is the cornerstone of anaesthesia and resuscitation. Incidence of difficult intubation by direct laryngoscopy is estimated to be between 4.5% and 7.5%. Laryngeal mask airway is a relatively recent advancement is the development of the supraglottic airway. Two of the more popular supra-glottic devices, the classic laryngeal mask airway (LMA) and proseal LMA, have good data in the pediatric population to support their safety and efficacy. Esophageal-Tracheal tube and Endotracheal Intubation is a supraglottic airway device frequently used by many emergency medical personnel that intentionally intubates the esophagus, but the design of the device allows ventilation via a two-cuffed system and a ported tube. They are popular because of their ease of administration. They come in different sizes, but their routine use does not routinely extend to pediatric airway management.

Airway Management Devices Market Scope and Summary

For more details on this report Request for Sample

Market Dynamics

Drivers

Rise in the prevalence of respiratory diseases

Increase prevalence of respiratory disease is one the key driver that helps the market to grow during forecast period. Since rise in respiratory diseases the use of airway management devices are often used rapidly which indeed will increase the market growth. For instance, according to the Centers for Disease Control and Prevention COPD affects an estimated 200 million people, with 3.2 million dying each year, making it the third-leading cause of mortality globally. Asthma is one of the most common noncommunicable illnesses, impacting 262 million people worldwide. With almost 2.2 million new instances of lung cancer expected in 2022 and 1.80 million fatalities, lung cancer accounts for one in every four cancer deaths worldwide. Lower respiratory tract infection or pneumonia is a prominent cause of death, accounting for more than 2.4 million fatalities each year, primarily in low and middle-income countries (LMICs). COVID-19 has significantly increased pneumonia fatalities worldwide. According to the Global Asthma Network (GAN) Phase I surveyed 101,777 children in 44 centres within 16 countries, 157,784 adolescents in 63 centres, within 25 countries, and 193,912 adults (54% female; median age 38, interquartile range 33, 43) in 43 centres within 17 countries. The overall prevalence of current asthma symptoms in GAN Phase I was 9.1% for children, 11.0% for adolescents, and 6.6% for adults. This differed by country income level with lower prevalences across all three age groups in low- to lowermiddle-income countries and highest prevalences in high-income countries.

Advancement in airway management technology

Rise in developing technologically advanced devices in airway management is one of the key driver that helps the airway management devices market to grow during the forecast period. A wide range of airway devices and techniques have been created to enhance the safety of airway management. All techniques are susceptible to failure. Therefore, it is necessary to have and know the greatest number of alternatives to treat even the most challenging airway successfully. Many devices have been launched into market by key players some of the mare like, Video Laryngeal Masks, Articulated Stylets, Laryngeal Mask Insertion, Endotracheal Intubation and others. Airway management is one of the most important tasks of clinical anesthesia, intensive care unit, and emergency rescue. Difficult airway is associated with a higher rate and severity of complications, which is a cause of death during anesthesia. Airway management has been the focus in the field of anesthesiology. In recent 10 years, the definition of difficult airway has changed. Several institutions and organizations have updated the guidelines for the management of difficult airway for different patients, making progress in the evaluation of difficult airway, ventilation methods for application in difficult airway, use of devices, monitoring, training, and artificial intelligence for application in difficult airway

Restraints

Adverse effects associated with airway management devices

Supraglottic airway devices are routinely used for airway maintenance in elective surgical procedures where aspiration is not a significant risk and also as rescue devices in difficult airway management. Some devices now have features mitigating risk of aspiration, such as drain tubes or compartments to manage regurgitated content. Despite this, the use of these device may be associated with various complications including aspiration. The incidence of gastric content aspiration associated with the devices is estimated to be as low as 0.02% with perioperative regurgitation being significantly higher but underreported. Other serious, but extremely rare, complications include pharyngeal rupture, pneumomediastinum, mediastinitis, or arytenoid dislocation. Mild short-lasting adverse effects of the devices have significantly higher incidence than serious complications and involve postoperative sore throat, dysphagia, pain on swallowing, or hoarseness. Devices may have deleterious effect on cervical mucosa or vasculature depending on their cuff volume and pressure. Complications associated with the correct use of the SGAs are relatively rare and most of them are not lifethreatening. They are often associated with a deviation from the manufacturers’ advice on usage of their devices. Aspiration remains a problem, which can have serious and even fatal consequences.

Covid Airway Management Workflow

During the pandemic rapid sequence induction was performed, laryngoscopy devices used, the use of apneic oxygenation, bag-mask ventilation, and supraglottic airway devices was seen enormously. As with many other practices during the pandemic, airway management strategies have changed rapidly during this period despite the paucity of strong evidence. Recommendations were published early on in the pandemic by expert clinicians to guide professionals on tracheal intubation practices to maximize patient and healthcare worker safety. Common themes of these recommendations included limiting the number of personnel involved in the procedure, wearing appropriate personal protective equipment, deploying the most skilled airway manager to perform airway management interventions, using videolaryngoscopy as the primary intubation device, and avoiding the use of potential aerosol-generating procedures such as high-flow nasal oxygenation and bag-valve-mask ventilation.

Segmentation Analysis

The market value for endosteal implants is likely to reach USD XX million in 2031, from its recorded value of USD XX million in 2023, growing with a CAGR of XX% during the forecast period 2024 to 2031. A laryngoscope – also known as a laryngeal mirror – is a medical instrument that is used to view the upper respiratory tract and larynx. It consists of a handle and a curved blade with an integrated light conductor that is inserted into the patient’s mouth to help lift the epiglottis. This enables practitioners to accurately perform procedures, such as placing a breathing tube during endotracheal intubation. Among the devices with video displays, Airtraq laryngoscope (AL), Glidescope video laryngoscope (GVL), Pentax-AWS and McGrath video laryngoscope have been successfully used in both normal and difficult airways.

In June 2023, a study led by US-based Vanderbilt University Medical Center has demonstrated that a video laryngoscope enhances successful intubation on the first attempt. The Direct Versus Video Laryngoscope trial compared video laryngoscope and direct laryngoscope for tracheal intubation of critically ill patients. It revealed that a video laryngoscope increased successful intubation compared to the use of a direct laryngoscope. The study compared the two devices that are used to intubate patients in the intensive care unit (ICU) and the emergency department. Conventional airway management involves use of the mask, the direct laryngoscope and the endotracheal (ET) tube, whereas fibreoptic bronchoscope has been the gold standard for access and intubation in difficult airways. Over the years, continued incidences of hypoxia during airway management led to efforts to devise effective alternatives. For instance, in September 2023, Penlon announced the launch of a high-definition image from a camera on the distal end of the blade, giving an increased field of view compared with direct laryngoscopy. The 3.5-inch colour touchscreen of the Diamond Video Laryngoscope provides clinicians with a clear and detailed view of the patient’s larynx, with anti-fogging as standard. The compact, ergonomic handle houses a high-capacity rechargeable battery providing up to 4 hours of use from a full charge. Also, in April 2022, OMNIVISION, a leading global developer of semiconductor solutions, including advanced digital imaging, analog and touch & display technology, launched new laryngoscope reference designs that include a range of OMNIVISION products that help improve patient care by providing crisp, clear images for single-use video laryngoscopes. Visualization makes insertion of the endotracheal tube easier and faster and avoids failures in difficult airways, significantly reducing the chances of complications and even death.

Region Analysis

The North America airway management devices market is likely to reach USD XX million in 2031, from its recorded value of USD XX million in 2023, growing with a CAGR of XX% during the forecast period 2024 to 2031. The total count of airway management procedures performed in North America was 74,523,145 in 2022. Airway management procedures include airway management tube procedures, airway management mask procedures, and intubation accessory procedures. In recent years, the numbers of airway tumors, airway stenosis, airway reconstruction surgeries involving subglottic airway management are more than before. These kinds of surgeries require both surgeons and anesthesiologists to control the airway, so these kinds of complicated surgeries are not limited to simple endotracheal intubation but need some special airway devices and methods.

Company Share Analysis

The global airways management devices market is expected to be moderately competitive, owing to the presence of big brands. Also, the market is expanding due to the presence of several large and regional players entering the market. The key players that are contributing to the growth of the global market include Intersurgical Ltd, Medtronic Plc, Olympus Corporation, ICU Medical, Inc, ConvaTec Group Plc, KARL STORZ, Teleflex Incorporated , Ambu A/S, Verathon Inc, SourceMark, Stryker among others. The key players are adopting strategies such as partnerships, mergers, acquisitions and regional expansion to stand out as strong competitors in the market. Novel services and enhanced focus on research and development are other ways the leading players can improve their market presence.